| Literature DB >> 26887231 |
Jingfeng Lou1, Ruiting Yu1, Xiaohan Wang1, Ziling Mao1, Linyun Fu1, Yang Liu2, Ligang Zhou3.
Abstract
One bioactive compound, identified as alternariol 9-methyl ether, was isolated from the crude extract of the endophytic fungus Alternaria sp. Samif01 residing in the roots of Salvia miltiorrhiza Bunge. Alternariol 9-methyl ether was active against bacteria with minimum inhibitory concentration values ranging from 25 to 75μg/mL and median inhibitory concentration (IC50) values ranging from 16.00 to 38.27μg/mL. The IC50 value of alternariol 9-methyl ether against spore germination of Magnaporthe oryzae was 87.18μg/mL. Alternariol 9-methyl ether also showed antinematodal activity against Bursaphelenchus xylophilus and Caenorhabditis elegans with IC50 values of 98.17μg/mL and 74.62μg/mL, respectively. This work is the first report on alternariol 9-methyl ether and its biological activities from the endophytic fungus Alternaria sp. Samif01 derived from S. miltiorrhiza Bunge. The results indicate the potential of Alternaria sp. Samif01 as a source of alternariol 9-methyl ether and also support that alternariol 9-methyl ether is a natural compound with high potential bioactivity against microorganisms.Entities:
Keywords: Alternaria sp., Alternariol 9-methyl ether; Bioactivity; Endophytic fungus; Salvia miltiorrhiza Bunge
Mesh:
Substances:
Year: 2016 PMID: 26887231 PMCID: PMC4822747 DOI: 10.1016/j.bjm.2015.11.004
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Fig. 1The colony front view (A), conidiospores (B) and phylogenetic tree (C) of the endophytic fungus Alternaria sp. Samif01 from S. miltiorrhiza.
Fig. 2HR-ESI-MS spectrum (A), 1H NMR spectrum (B) at 400 MHz and 13C NMR spectrum (C) at 100 MHz of alternariol 9-methyl ether in DMSO-d6. The chemical shifts are shown in ppm with TMS as an internal standard.
Fig. 3Chemical structure of alternariol 9-methyl ether.
Biological activities of alternariol 9-methyl ether.
| Test organism | Alternariol 9-methyl ether (μg/mL) | CK+ (μg/mL) | ||
|---|---|---|---|---|
| MIC | IC50 | MIC | IC50 | |
| 75.0 | 38.07 ± 2.78 | 25.0 | 11.96 ± 1.25 | |
| 50.0 | 22.83 ± 1.06 | 37.5 | 20.58 ± 0.88 | |
| 25.0 | 16.00 ± 0.30 | 25.0 | 4.69 ± 0.79 | |
| 75.0 | 38.27 ± 1.80 | 100.0 | 41.26 ± 2.41 | |
| 37.5 | 19.90 ± 1.62 | 12.5 | 4.24 ± 0.94 | |
| 75.0 | 31.99 ± 1.34 | 50.0 | 22.83 ± 1.37 | |
| nd | 87.18 ± 1.39 | nd | 6.25 ± 0.19 | |
| nd | 74.62 ± 0.62 | nd | 12.90 ± 0.27 | |
| nd | 98.17 ± 0.92 | nd | 14.00 ± 0.19 | |
Note: The positive controls (CK+) for bacteria, fungus and nematodes were streptomycin sulfate, carbendazim and avermectin, respectively. The ‘nd’ means not detected.